Soleno Therapeutics

(NASDAQ) SLNO

Current Price$52.80

Market Cap$2.72B

Since IPO (2014)-82%

5 Year+191%

1 Year-30%

1 Month+73%

Soleno Therapeutics Financials at a Glance

Market Cap

$2.72B

Revenue (TTM)

$190.41M

Net Income (TTM)

$20.89M

EPS (TTM)

$0.22

P/E Ratio

236.79

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$52.80

Volume

54,406

Open

$52.77

Price

$52.80

Volume

54,406

Open

$52.77

Previous Close

$52.80

Daily Range

$52.77 - $52.86

52-Week Range

$29.43 - $90.32

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$52.80

Volume

54,406

Open

$52.77

Previous Close

$52.80

Daily Range

$52.77 - $52.86

52-Week Range

$29.43 - $90.32

SLNO News

Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement

Josh Kohn-LindquistApr 6, 2026

Person in a lab gazing into a microscope

Why Soleno Therapeutics Stock Rocketed Higher on Monday

Eric VolkmanApr 6, 2026

Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet?

Jonathan PoncianoDec 3, 2025

Page 1

SLNO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Soleno Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

182

CEO

Anish Bhatnagar, MD

Website

www.soleno.life

Headquarters

Redwood City, CA 94065, US

SLNO Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

Net Income Margin

11%

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

0.42%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.72B

Shares Outstanding

51.62M

Volume

54.41K

Avg. Volume

3.40M

Financials (TTM)

Gross Profit

$187.71M

Operating Income

$14.95M

EBITDA

$28.38M

Operating Cash Flow

$46.80M

Capital Expenditure

$73.00K

Free Cash Flow

$46.73M

Cash & ST Invst.

$305.47M

Total Debt

$2.69M

Soleno Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$91.73M

N/A

Gross Profit

$90.87M

N/A

Gross Margin

99.06%

N/A

Market Cap

$2.72B

N/A

Market Cap/Employee

$23.69M

N/A

Employees

115

N/A

Net Income

$43.36M

+177.4%

EBITDA

$45.22M

+191.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$302.78M

+26.9%

Accounts Receivable

$28.21M

N/A

Inventory

$15.02M

N/A

Long Term Debt

$1.96M

-96.2%

Short Term Debt

$726.00K

+38.0%

Return on Assets

3.71%

N/A

Return on Invested Capital

2.04%

N/A

Free Cash Flow

$48.65M

+302.7%

Operating Cash Flow

$48.70M

+303.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DYNDyne Therapeutics, Inc.

DYNDyne Therapeutics, Inc.$17.41-4.13%

RAREUltragenyx Pharmaceutical Inc.

RAREUltragenyx Pharmaceutical Inc.$24.18-1.43%

AAPGAscentage Pharma Group International

AAPGAscentage Pharma Group International$22.48-2.26%

VKTXViking Therapeutics, Inc.

VKTXViking Therapeutics, Inc.$31.33-3.27%

XENEXenon Pharmaceuticals Inc.

XENEXenon Pharmaceuticals Inc.$55.75+2.24%

APGEApogee Therapeutics, Inc.

APGEApogee Therapeutics, Inc.$82.03-3.91%

MIRMMirum Pharmaceuticals, Inc.

MIRMMirum Pharmaceuticals, Inc.$94.20+0.21%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$15.54-0.15%

NVDANvidia

NVDANvidia$208.99-0.02%

INTCIntel

INTCIntel$94.75+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

QCOMQualcomm

QCOMQualcomm$156.04+0.04%

NOKNokia

NOKNokia$12.46+0.10%

AMDAdvanced Micro Devices

AMDAdvanced Micro Devices$336.38+0.04%

Questions About SLNO

What is the current price of Soleno Therapeutics?

Soleno Therapeutics is trading at $52.81 per share.

What is the 52-week range for Soleno Therapeutics?

Over the past 52 weeks, Soleno Therapeutics has traded between $29.43 and $90.32.

How much debt does Soleno Therapeutics have?

As of the most recent reporting period, Soleno Therapeutics reported total debt of $52.55M.

How much cash does Soleno Therapeutics have on hand?

Soleno Therapeutics reported $70.11M in cash and cash equivalents in its most recent financial results.

What is Soleno Therapeutics’s dividend yield?

Soleno Therapeutics does not currently have a dividend yield.

Soleno Therapeutics

Soleno Therapeutics Financials at a Glance

SLNO News

Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement

Why Soleno Therapeutics Stock Rocketed Higher on Monday

Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet?

Soleno (SLNO) Q2 Revenue Jumps 30%

Why Soleno Therapeutics Stock Blasted 9% Higher Today

Why Soleno Therapeutics Stock Is Skyrocketing Today

Why Soleno Therapeutics Stock Ticked Higher on Thursday

Why Shares of Soleno Therapeutics Dropped on Wednesday

SLNO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Soleno Therapeutics

SLNO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Soleno Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SLNO

What is the current price of Soleno Therapeutics?

What is the 52-week range for Soleno Therapeutics?

How much debt does Soleno Therapeutics have?

How much cash does Soleno Therapeutics have on hand?

What is Soleno Therapeutics’s dividend yield?

Premium Investing Services